Advertisement
ACT

APR. 19/2016

Advertisment

news roundup

FDA’s Breakthrough Drug Program is Working

A recent analysis finds that pre-market development time for breakthrough-designated drugs is 2.2 years shorter than for those without.


advertisment

Immuno-Oncology Insights:
Top 5 Challenges in Today's Immuno-Oncology Trials

On Demand
click here


LabCorp’s Covance Lab in Geneva Doubles Space

The Covance Central Laboratory in Geneva provides services for global clinical trials in Europe and Africa.

advertisment

Overcoming regulatory and statistical hurdles of biosimilars drug development Designing smarter trials
On Demand
click here


Parexel, EMC Join on Regulatory Documents

Agreement combines PAREXEL’s LIQUENT InSight RIM platform and EMC's Documentum.


advertisment

Mitigating risk using Risk-based Monitoring
On Demand
Learn how risk-based monitoring (RBM) is transforming clinical development by mitigating risk while optimizing execution. Understand how to achieve enhanced patient safety with improved quality to execute your RBM studies with confidence.
click here


Latest People, Company News

Updated people moves and company awards.

In this edition

FDA’s Breakthrough Drug Program is Working
Latest People, Company News
Pharma Sharing Tox Data
mHealth--3 Ways Clinical Trials Will be Transformed

advertisment

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Events

eSource Data in Clinical Investigations Summit
Fifth Annual Clinical Trial Innovation Summit
Search more events

Blog Posts

Pharma Sharing Tox Data

Mike Graziano, VP of Toxicology at Bristol-Myers Squibb, will elaborate on Biocelerate's toxicology data sharing initiative.


Pharmacists' Role in EU Healthcare

Pharmacists have new prominence in a new European system, created jointly with drugmakers and wholesalers and parallel traders.


mHealth

Study of eHealth Use in Rural Communities

There has been an increased interest in the potential of e-health and m-health in low- and middle-income countries.


3 Ways Clinical Trials Will be Transformed

A significant increase in usage of wearables and devices to collect patient data in clinical trials is likely as these devices can provide data such as mobility, sleep, heart rate that would otherwise be unavailable.

advertisment

Articles

Orphan Drug Market Overview

Governments and patient advocate organizations can incentivize pharmaceutical companies that engage in orphan drug development.


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Watch ACT TV for interviews with
Clinical Trials Experts


Ask the editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com

Advertise

Mike Tessalone
Publisher
mtessalone@advanstar.com